Nasopharyngeal carcinoma
Conditions
Interventions
Case series:NA
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 80 years; 2. Suspected or confirmed nasopharyngeal malignant tumors or patients with benign nasopharyngeal diseases; 3. Patients who intend to undergo surgical treatment; 4. Sufficient blood samples and tissue samples for detection and analysis; 5. Sign informed consent, good compliance.
Exclusion criteria
Exclusion criteria: 1. Hemolysis of plasma samples; 2. The blood sample has not been prepared into an analyzable sample within 24 hours; 3. Pregnant and lactating patients; 4. Received other anti-tumor therapy before surgery; 5. Patients with a history of other malignant tumors in the past. 6. The investigator believes that it may affect the compliance of the protocol, or affect the patient's signing of the informed consent form (ICF), or any other clinically significant disease or condition that is not suitable for participating in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ability to distinguish benign and malignant lesions of nasopharynx; | — |
Countries
China
Contacts
Public ContactHu Guangyuan
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Outcome results
None listed